ABCB1 and ABCG2 restrict the brain penetration of a panel of novel EZH2-Inhibitors.
about
Celecoxib enhances [sorafenib + sildenafil] lethality in cancer cells and reverts platinum chemotherapy resistanceABCG1 maintains high-grade glioma survival in vitro and in vivo.Inhibitors of protein methyltransferases as chemical tools.Therapeutic Potential and Utility of Elacridar with Respect to P-glycoprotein Inhibition: An Insight from the Published In Vitro, Preclinical and Clinical Studies.Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatmentTransgenerational programming of longevity through E(z)-mediated histone H3K27 trimethylation in DrosophilaSmall molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells.The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells.Targeting glioma stem cells through combined BMI1 and EZH2 inhibition.The impact of P-glycoprotein and breast cancer resistance protein on the brain pharmacokinetics and pharmacodynamics of a panel of MEK inhibitors.Epigenetic regulation in medulloblastoma.Structure-Activity Relationship Studies on 6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline Derivatives as Multidrug Resistance Reversers.Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program.Pyrazole-based inhibitors of enhancer of zeste homologue 2 induce apoptosis and autophagy in cancer cells.Modulation of the ATP-Binding Cassette B1 Transporter by Neuro-Inflammatory Cytokines: Role in the Pathogenesis of Alzheimer's Disease.Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2.Next-Generation Modeling of Human Cancers
P2860
Q36839023-8E0B6B6A-5873-479F-AFBF-0A9C08E7080CQ37269034-1B21BCE9-7F65-4C2B-8807-CBB4CF1C63D9Q38662560-9ECBF5CB-041B-4557-B3A2-DDD1FC250941Q38856951-7521C4EC-1C02-4D14-B0BA-5CD63BFA45A0Q40014635-D736A4B3-9D1D-4E38-AE6D-9C28D6DD4680Q40027583-D53FFA5B-FB9B-48EB-8EA3-E5012453E4F1Q42321107-553EC9F4-3B3C-45E3-96CD-362A09F55646Q42366629-A607F6F5-1FDE-4CCE-A1E6-E9ABF88D8319Q47648829-EB4A6352-083B-4627-B62E-7B49B052405CQ47786514-E439A42A-EC08-409A-B3F0-FDF86ADB95AAQ47900778-47E5EC8C-348D-4C91-83A1-D0E6F8B7789EQ48344291-59E81784-CAA5-4F13-A2E4-28DD3A5506B8Q50324483-A4702EB0-BBB2-4C2B-AE6C-CD8BE8396BADQ52568730-F3500AA2-234B-48A6-8938-46293ECA71DCQ55404360-00C769B9-6CFC-4782-A8AC-81D1A037C6FDQ55500980-857DF99F-24FF-44E9-85A7-ECFDEF529F7FQ58576103-0370526B-45C5-4704-8656-42E78800EE3C
P2860
ABCB1 and ABCG2 restrict the brain penetration of a panel of novel EZH2-Inhibitors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
ABCB1 and ABCG2 restrict the brain penetration of a panel of novel EZH2-Inhibitors.
@en
type
label
ABCB1 and ABCG2 restrict the brain penetration of a panel of novel EZH2-Inhibitors.
@en
prefLabel
ABCB1 and ABCG2 restrict the brain penetration of a panel of novel EZH2-Inhibitors.
@en
P2093
P2860
P356
P1476
ABCB1 and ABCG2 restrict the brain penetration of a panel of novel EZH2-Inhibitors
@en
P2093
Jos H Beijnen
Levi C M Buil
Olaf van Tellingen
Ping Zhang
P2860
P304
P356
10.1002/IJC.29566
P577
2015-04-24T00:00:00Z